Article
Princeton, NJ-Advanced Biomedical Research Inc. has launched a new ophthalmic division, called ABR InVision, devoted to conducting clinical studies in glaucoma, retinal and corneal diseases, cataract, refractive surgery, and neuroprotection.
EyePoint Pharmaceuticals announces first patient dosed in global Phase 3 LUGANO clinical trial of Duravyu for wet AMD
Week in Review - October 5, 2024
Study estimates glaucoma and vision-affecting glaucoma prevalence by demographic factors
Innovation Series: AI’s impact on managing ocular surface disease with Peter J. McDonnell, MD, and Laura M. Periman, MD
The top 10 takeaways from AAO 2024
Real-world evidence on latest retinal disease therapies